🇬🇧 United Kingdom Country × Condition
ovarian cancer Clinical Trials in United Kingdom
Active clinical trials for ovarian cancer with research sites in United Kingdom. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 2, Phase 1 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇬🇧 United Kingdom
Active Trials in United Kingdom (3)
NCT06504147 Phase 2
Recruiting
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
Enrollment
114 pts
Country
🇬🇧 United Kingdom
Oncoinvent Solutions AS
View Trial → NCT05104515 Phase 1
Recruiting
First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine
Enrollment
36 pts
Country
🇬🇧 United Kingdom
Oxford Vacmedix UK Ltd.
View Trial → NCT06129968
Recruiting
Transforming Ovarian Cancer Diagnostic Pathways
Enrollment
34,000 pts
Country
🇬🇧 United Kingdom
Professor Sudha Sundar
View Trial → Frequently Asked Questions
How many ovarian cancer clinical trials are active in United Kingdom?
There are currently 3 active clinical trials for ovarian cancer with sites in United Kingdom, of which 3 are actively recruiting patients.
How can I join a ovarian cancer clinical trial in United Kingdom?
To join a ovarian cancer clinical trial in United Kingdom, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United Kingdom directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are ovarian cancer trials in United Kingdom?
Active ovarian cancer trials in United Kingdom span Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology